Somatic mutations in the gene encoding epidermal growth factor receptor (EGFR) play a significant role in deciding targeted treatment modalities in non-small cell lung cancer (NSCLC). a report evaluating efficiency and basic safety of gefitinib [26]. Within a combination platform comparison research, the concordance for T790M mutation between plasma and ctDNA was 57%, 48%, 74%… Continue reading Somatic mutations in the gene encoding epidermal growth factor receptor (EGFR)